Benjamin Bradley, MD, PhD, joined ARUP’s team of medical directors amid the monkeypox outbreak. Now, his new research aims to help labs improve testing.
Based on data from 21,916 participants in 33 studies, the Association for the Advancement of Blood and Biotherapies (AABB) has issued guidelines for use of convalescent plasma in COVID-19 treatment.
The National Institute of Allergy and Infectious Diseases has awarded Medical Director Allison Carey, MD, PhD, $1.5 million over five years to fund her groundbreaking research.
ARUP Consult has released several new and updated resources for clinicians, including testing topics on kidney evaluation, gestational trophoblastic disease, and poliovirus.
The CDC recently confirmed the first U.S. case of polio since 2013, which has raised concerns about the virus. New ARUP Consult resources inform clinicians about lab testing for poliovirus.
A new study for which ARUP provided COVID-19 testing and expertise found that emergency department workers early in the pandemic faced the highest risk of infection from community spread.
ARUP Consult, a free source of expert guidance in laboratory testing, offers valuable information on relevant topics from monkeypox to HLA testing and more.
ARUP has launched a new, in-house test to detect the DNA of orthopoxviruses, including monkeypox.
ARUP’s Dan Anderson will participate in a SmartBrief webinar on June 16 to share lessons learned from COVID-19 in an effort to help laboratories prepare for future pandemics.
As of May 23, multiple cases of monkeypox, a rare zoonotic infection endemic to Central and West African countries, had either been confirmed or were being investigated in at least six U.S. states.
ARUP Consult has released new and updated resources on testing for viral hepatitis and nephrolithiasis (i.e., kidney stone disease).
ARUP was among a few blood centers that contributed COVID-19 convalescent plasma (CCP) to a national clinical trial that found a >50% reduction in risk of hospitalization with early CCP treatment.